BiomX Inc. (PHGE) Form 8-K — Aug 11, 2026
$PHGEForm 8-KItems 1.01, 3.02, 9.01Filed Aug 11, 2026, 4:50 PM ET0001213900-26-087839Original filing
BiomX Inc. entered into a Share Purchase and Option Agreement with Mayers Ventures LLC to acquire 324,573 shares of Israel-based M.E.A. Testing Systems Ltd., a 10% fully diluted stake, for $50,000 in cash plus 1,300,000 restricted BiomX common shares. MEA develops advanced electric motor testing and validation systems, including drone testing technology, with customers understood to include Israel Aerospace Industries and Elbit Systems.
Key figures
- Cash payment
- 50000
- Outside date
- September 30, 2026
- Purchased shares
- 324573
- Option expiration
- June 30, 2028
- Mea ordinary shares
- 1719819
- Consideration shares
- 1300000
- Mea preferred shares
- 1525915
- Option stake percent
- approximately 78.9% post-closing
- Option ebitda multiple
- 4x MEA Companies FY2027 EBITDA
- Mea total issued shares
- 3245734
- Option revenue multiple
- 2x MEA Companies FY2027 Net Revenue
- Purchased stake percent
- 10% fully diluted
- Motomova ownership percent
- approximately 88.9% of MEA total issued share capital
Price after filing
1 day: -89.6%7 days: -14.4%30 days: +2.0%
Close on the filing date to close N calendar days later (from $1.59). Historical, not a forecast.
AI analysis
Red flags6 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.